As of March 2024 Esperion Therapeutics has a market cap of $0.49 Billion. This makes Esperion Therapeutics the world's 6043th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.49 B | 45.86% |
2023 | $0.34 B | -25.93% |
2022 | $0.45 B | 50.75% |
2021 | $0.30 B | -54.81% |
2020 | $0.67 B | -58.91% |
2019 | $1.63 B | 32.88% |
2018 | $1.23 B | -28.46% |
2017 | $1.72 B | 510.84% |
2016 | $0.28 B | -43.66% |
2015 | $0.50 B | -39.08% |
2014 | $0.82 B | 290.3% |
2013 | $0.21 B |
On Mar 28th, 2024 the market cap of Esperion Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $157.13 B | 31,584.24% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $105.64 B | 21,201.85% | ๐บ๐ธ USA |
Ultragenyx RARE | $3.84 B | 675.14% | ๐บ๐ธ USA |
Lexicon Pharmaceuticals
LXRX | $0.59 B | 19.16% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $3.47 B | 601.62% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $16.47 B | 3,222.76% | ๐บ๐ธ USA |